Trial intelligence / Profile preview

Fibrinogen concentrate versus placebo for postpartum haemorrhage

2012-005511-11Phase 2Completed

Sponsor
Cardiff University
Start
Mar 2013
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Fibrinogen concentrate with Placebo (2 arms). Primary endpoint: Total allogeneic blood product transfusion within 24 hours. Started Mar 2013; status: completed.

02

Drugs

Fibrinogen human
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on 2012-005511-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005511-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call